Skip to main navigation
Skip to search
Skip to main content
Houston Methodist Scholars Home
Search by expertise, name or affiliation
A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations
Baskin, David S.